In in vivo experiments, when further combined with CTLA-4, the primary and metastasis sites of the tumor were completely inhibited while substantial helper CD4+ and cytotoxic CD8+ T cells infiltrations were detected in the metastatic sites. The gene discussed is CTLA4; the disease is neoplasm.